z-logo
open-access-imgOpen Access
P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB
Author(s) -
Stephen P. McAdoo,
Sherry Masoud,
Rachna Bedi,
Thomas Cairns,
Liz Lightstone
Publication year - 2016
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2016.09.012
Subject(s) - ofatumumab , medicine , rituximab , cd20 , monoclonal , monoclonal antibody , immunology , malignancy , oncology , antibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom